HC Wainwright Issues Pessimistic Outlook for SMMT Earnings

Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for Summit Therapeutics in a research note issued on Tuesday, February 25th. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($0.09) per share for the quarter, down from their previous estimate of […]

Mar 1, 2025 - 07:26

Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for Summit Therapeutics in a research note issued on Tuesday, February 25th. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($0.09) per share for the quarter, down from their previous estimate of […]